A detailed history of Iron Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Iron Financial, LLC holds 227 shares of LLY stock, worth $178,919. This represents 0.11% of its overall portfolio holdings.

Number of Shares
227
Previous 296 23.31%
Holding current value
$178,919
Previous $267,000 24.72%
% of portfolio
0.11%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $53,277 - $66,241
-69 Reduced 23.31%
227 $201,000
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.34%
296 $267,000
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $174,699 - $233,722
295 New
295 $229,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Iron Financial, LLC Portfolio

Follow Iron Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.